Security key
92941V308
VYNE Therapeutics Inc. - common stock, par value $0.0001 (VYNE)
CUSIP: 92941V308
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / common stock, par value $0.0001
- Total 13F shares
- 7,109,939
- Total 13F value
- $11,401,092
- Share change
- +82,015
- SEC-reported price per share
- $1.58
- Number of holders
- 36
- Value change
- -$2,382,241
- Number of buys
- 21
- Number of sells
- 11
- Shares outstanding
- 33,403,382
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
36
Top holders
10
VYNE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
VYNE Therapeutics Inc. SEC filings
VYNE Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92941V308
Recent filing periods:
Ownership snapshot
Top reported holders of VYNE - VYNE Therapeutics Inc. - common stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Cormorant Asset Managemen...
Disclosed value leader
Cormorant Asset Managemen...
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 4.2%
Showing 1-6 of 15 holder rows.
Quick read
Cormorant Asset Management, LP leads the comparable SEC ownership view at 4.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Cormorant Asset Management, LP's linked filing trail.
Comparable ownership
Top 5
Cormorant Asset Management, LP
4.2%
EVENTIDE ASSET MANAGEMENT, LLC
4.2%
CITADEL ADVISORS LLC
3.7%
VANGUARD GROUP INC
1.4%
ACORN CAPITAL ADVISORS, LLC
1.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP |
13F
Company
|
4.2%
|
$4,671,026
1,394,336 shares
|
— | 31 Dec 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
4.2%
|
$4,447,932
1,394,336 shares
|
— | 31 Dec 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
3.7%
|
$4,122,031
1,230,457 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
1.4%
|
$1,591,682
475,129 shares
|
— | 31 Dec 2024 |
| ACORN CAPITAL ADVISORS, LLC |
13F
Company
|
1.4%
|
$1,530,850
456,970 shares
|
— | 31 Dec 2024 |
| Palo Alto Investors LP |
13F
Company
|
1.3%
|
$1,492,204
445,434 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
36
Shares
7,109,939
Rows available
36
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2026 Across Filers
Q1 2026 holders
42
Q1 2025 holders
36
Holder diff
-6
| Investor | Q1 2026 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend